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Chronic inflammation constitutes an important
link between obesity and its pathophysiological
sequelae. In contrast to the belief that inflammatory
signals exert a fundamentally negative impact on
metabolism, we show that proinflammatory signaling
in the adipocyte is in fact required for proper adipose
tissue remodeling and expansion. Three mouse
models with an adipose tissue-specific reduction in
proinflammatory potential were generated that
display a reduced capacity for adipogenesis in vivo,
while the differentiation potential is unaltered
in vitro. Upon high-fat-diet exposure, the expansion
of visceral adipose tissue is prominently affected.
This is associated with decreased intestinal barrier
function, increased hepatic steatosis, and metabolic
dysfunction. An impaired local proinflammatory
response in the adipocyte leads to increased ectopic
lipid accumulation, glucose intolerance, and sys-
temic inflammation. Adipose tissue inflammation is
therefore an adaptive response that enables safe
storage of excess nutrients and contributes to a
visceral depot barrier that effectively filters gut-
derived endotoxin.
INTRODUCTION
Adipose tissue expansion in response to excess caloric intake is
an important systemic response to avoid the lipotoxic side
effects exerted by excess lipid and fatty acid (FA) deposition in
cells other than adipocytes. The basic mechanisms, leading to
a gradual and ‘‘healthy’’ expansion of fat pads, are starting to
be elucidated. Healthy expansion is associated with appropriate
angiogenesis and vascular and extracellular matrix (ECM)
remodeling.
Increased adiposity is more often than not associated with an
increased risk for a number of chronic diseases, including
diabetes, cardiovascular disease, and some types of cancers
(Park et al., 2011). The underlying mechanisms for the linkbetween obesity and these diseases are not fully understood
but are likely to involve a state of chronic systemic low-grade
inflammation.
The causality between local adipose tissue inflammation, sys-
temic inflammation, and metabolic dysfunction has, however,
not been studied. Therefore, we developed three distinct but
complementary mouse models to investigate the role of adipose
tissue inflammation in high-fat-diet (HFD)-induced metabolic
disturbances. By design, twomodels express the anti-inflamma-
tory factors in adipose tissue constitutively, while one model is
inducible.
Analysis of these three mouse models reveals that the inability
to mount an appropriate local proinflammatory response at the
level of the adipocyte reduces adipose tissue expansion under
normal physiological as well as under HFD-fed conditions. This
inability to expand adipose tissue is associated with ectopic lipid
deposition and a deterioratedmetabolic profile. Furthermore, we
demonstrate that mesenteric adipose tissue (MWAT, a visceral
fat depot) plays an important role for proper intestinal barrier
function. An ineffective response of MWAT to proinflammatory
stimuli with respect to its expansion is associated with a ‘‘leaky
gut,’’ colitis, and metabolic dysfunction. Thus, these mouse
models demonstrate that a local inflammatory response derived
from the adipocyte is an adaptive response and an important
preemptive factor for ensuing obesity-associated systemic
inflammation.
RESULTS
We have recently developed a mouse model (the ‘‘adipochaser
mouse’’) in which we can permanently activate b-galactosidase
expression in all preexisting adipocytes by a short bout of doxy-
cycline treatment. Removal of doxycycline enables the detection
of newly differentiated adipocytes that are negative for the blue
X-Gal-LacZ staining (Wang et al., 2013). Repeated local LPS in-
jections into adipose tissue stimulate adipogenesis without
affecting overall weight gain (Sadler et al., 2005). Exploiting our
adipochaser mouse, we are able to confirm the findings by
Sadler and colleagues. New adipocyte formation was evident
in the LPS-injected inguinal WAT (IWAT) depot, but not in the
control depot (Figure 1A and data not shown). These observa-
tions suggest that the induction of acute inflammation in theCell Metabolism 20, 103–118, July 1, 2014 ª2014 Elsevier Inc. 103
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Figure 1. Reduced Fat Mass and Glucose Tolerance in dnTNF tg Mice
(A) X-Gal-LacZ stained LPS-injected Adipochaser IWAT (blue, preexisting adipocytes; white, new adipocytes).
(B and C) Leptin and body weight change after i.p. injection with 0.3 mg/kg LPS in dnTNF tg and wild-type female mice.
(D) IWAT and GWAT weight in relation to body weight in chow (top) and HFD-fed (bottom) male dnTNF tg and wild-type controls.
(E–H) Body weight, glucose tolerance test, serum adiponectin, and SAA levels in male dnTNF tg and littermate controls after 11 weeks of HFD feeding.
(I) Representative Trichrome stain of IWAT in male dnTNF tg and littermate controls after 11 weeks of HFD feeding.
(legend continued on next page)
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We therefore hypothesized that acute inflammation within
adipose tissue may play an essential role for adipose tissue
expansion, remodeling, and overall homeostasis by stimulating
ECM degradation and angiogenesis. To study the role of inflam-
mation in adipose tissue, we developed amousemodel express-
ing a dominant-negative version of the potent proinflammatory
cytokine TNF-a (dnTNF) (Steed et al., 2003) under the control
of the ap2 promoter (‘‘dnTNF tg’’). This is a version of TNF-a
that effectively heterotrimerizes with wild-type TNF-a subunits,
but the presence of a mutant subunit engages the TNF receptors
nonproductively. aP2 promoter-driven constructs are predomi-
nantly transcribed in adipocytes, but expression has been
reported in macrophages and other tissues, such as the heart
and the brain, though at much lower levels. Our dnTNF tg mice
express the transgene specifically in adipose tissue, but also
to a minor extent in isolated peritoneal macrophages (see Fig-
ure S1A available online). The low level of dnTNF expression in
macrophages does not affect the inflammatory state of thiogly-
collate-activated peritoneal macrophages, since a number of
cytokines and M1/2 markers (e.g., TNF-a, IL-1b, TGF-b, Arg1,
and CD11c) remained unaltered compared to macrophages iso-
lated from littermate controls (Figure S1B).
As expected, unchallenged chow-fed dnTNF tg do not display
significant differenceswith respect to genes involved in inflamma-
tion or macrophage polarization, e.g., TNF-a, F4/80, CD11c,
NOS2, CD206, and CD301 in adipose tissue (data not shown).
However, the dnTNF tg mice display a reduced NFkB activation
in adipose tissue (as judged by reduced IkBa phosphorylation) in
response to an intraperitoneal injection with TNF-a (Figure S1C).
Furthermore, LPS induces a highly specific response on adipo-
cytes in adipose tissue, leading to an acute increase in serum lep-
tin levels. In the presenceof dnTNF, this LPS-mediated increase in
serum leptin levels is significantly blunted (Figure 1B). This indi-
cates that an autocrine TNF-a loop is part of the LPS-mediated
effects on leptin release. Despite the increase in serum SAA and
a1acid-glycoprotein (Figure S1D and data not shown), the body
weight recovery is slightly faster in the dnTNF tg mice (Figure 1C).
Combined, these results confirm that the dnTNF transgene is
indeed functional, and that it exerts its effects primarily at the level
of adipose tissue,while leaving the inflammatory response inother
tissues, such as the liver, fully intact.
Reduced Body Weight, Fat Mass and Glucose Tolerance
in HFD-Fed dnTNF tg Mice
In young chow-fed mice, the body weights trend to be lower in
the dnTNF mice. The IWAT weight is reduced, while the gonadal
WAT (GWAT) weight is similar between genotypes (Figure 1D).
This pattern changes upon HFD feeding. The degree of HFD-
induced obesity is reduced in the dnTNF mice (Figure 1E). This
is particularly apparent in GWAT, which is much more promi-
nently affected than the IWAT depot in HFD-fedmice (Figure 1D).
In absolute terms, both GWAT and IWAT are of reduced size in
HFD-fed dnTNF tg mice compared to littermates. The reduced(J) Representative perilipin (red) and mac2 (brown) immunostain in GWAT after
represent SEM; p < 0.05 according to Student’s t test was considered significant
genotype, #difference from initial weight). p values in red indicate difference be
surement ANOVA.IWAT weight is, however, proportional to the lower body weight
in the dnTNF mice. Brown adipose tissue (BAT) and MWAT are,
however, of similar sizes in dnTNF and littermate controls,
regardless of diet (data not shown). Similar results were seen
when the dnTNF transgene was bred into the genetically obese
ob/ob background, indicating that there are leptin-independent
mechanisms responsible for the reduced body and GWAT
mass weight in dnTNF mice (Figure S1E).
Wewent on to test whether the reduced bodyweight translates
into the expected improvements in metabolic parameters. To our
surprise, HFD-fed dnTNF tg mice are severely glucose intolerant
and have lower adiponectin levels, despite lower levels of circu-
lating SAA compared to littermate controls (Figures 1F–1H).
These observations suggest that adipose tissue TNF-a
signaling is relevant for adipose tissue remodeling and expan-
sion. Consistent with this hypothesis, we found increased
amounts of ECM deposits in IWAT of HFD-fed dnTNF mice
compared to littermate controls (Figure 1I). This result is consis-
tent with a need for TNF-a for successful ECM remodeling in the
context of wound healing (Heo et al., 2011; Saika et al., 2006).
The HFD-induced adipocyte hypertrophy in IWAT is similar
between genotypes (relative adipocyte sizes 1.00 ± 0.3
and 0.94 ± 0.1 for, respectively, wild-type and dnTNF tg IWAT;
p = 0.84), despite about 60% reduced IWAT depot weight in
the dnTNF tg mice (Figure 1D), suggesting that inhibition of
TNF-a-signaling either causes a reduced capacity for adipogen-
esis in vivo or may simply be secondary to the increased fibrosis.
Disruption of this fibrotic state, such as in the context of HFD-
exposed mice lacking collagen VI (Khan et al., 2009), reduces
adipocyte apoptosis. In contrast, enhanced fibrosis increases
the rate of adipocyte death (Halberg et al., 2009). In line with
fibrosis-induced adipocyte death, prolonged HFD-feeding
(22 weeks) leads to an increased presence of crown-like struc-
tures (CLSs) in the GWAT of dnTNF tg mice. This is apparent
when examining infiltrating macrophages (as judged by Mac2
staining) surrounding dead adipocytes (as judged by perilipin-
negative staining) (Figure 1J). We did not, however, detect a
difference in adipocyte death rates in IWAT, and no difference
was observed in GWAT at earlier stages of HFD feeding (data
not shown). Thus, a reduction in adipogenesis is more likely to
explain the enlarged adipocytes in IWAT and the reduced
GWAT size in HFD-fed dnTNF tg mice.
Essential Role for Acute Inflammation for Adipose
Tissue Functionality
Given the many studies showing the negative impact of TNF-a
on insulin sensitivity as well as on adipocyte differentiation
(Engelman et al., 2000; Gustafson and Smith, 2006; Hotamisligil
et al., 1993), the metabolic and adipose tissue dysfunction seen
in the dnTNF tg mice is rather surprising at first sight. However,
our observations do not contradict a model in which chronic
inflammation is an important contributor toward the metabolic
syndrome. Rather, though, ‘‘immunologic fitness’’ as we have
previously defined it (Asterholm et al., 2012), seems to be an22 weeks of HFD feeding in male dnTNF tg and littermate control. Error bars
and is indicated by */#; **/##p < 0.01; ***/###p < 0.001 (*difference in between
tween groups during the indicated time course according to repeated-mea-
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Figure 2. Reduced Fat Mass and Reduced Glucose Tolerance in RID tg Mice
(A) LPS (0.3 mg/kg)-induced body weight change in male RID tg and wild-type controls.
(B) Gene expression in GWAT harvested from male RID tg and wild-type controls 6 hr after LPS injection.
(legend continued on next page)
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adipose tissue in particular. To further explore this concept of
‘‘physiological adipose tissue inflammation,’’ we wanted to test
an additional model to strengthen the general validity of our initial
findings in these dnTNF tg mice. To do so, we generated a more
potent adipose-specific anti-inflammatory model. This second
mouse model takes advantage of RIDa/b (RID), an adenoviral
protein complex that suppresses the local host immune
response by potently inhibiting a number of proinflammatory
signaling pathways (e.g., TLR4-, TNF-a- and IL-1b-mediated
signaling) (Lichtenstein et al., 2004; Delgado-Lopez and Horwitz,
2006). Similar to the dnTNF tgmice, we put the expression of RID
under the control of the aP2 promoter (RID tg). Just as for the
dnTNF tg mouse model, we detected a high transgene expres-
sion in adipocytes with low level expression also seen in macro-
phages, but not in other tissues (Figure S2A). Upon isolating
fresh peritoneal thioglycollate-stimulated macrophages from
wild-type and RID mice, we did not detect any difference in
macrophage function, suggesting that the trace levels of expres-
sion do not amount to an effective suppression of inflammation in
macrophages (Figure S2B). Consistent with a potent action
within the adipocyte, the RID tgmice display a significantly blunt-
ed response to LPS in adipose tissue, associated with a reduced
response to LPS-induced body weight loss as well (Figures 2A
and 2B). Moreover, and also similar to the dnTNF tg mice, fat
pad weights of the RID tg mice are reduced. The more effective
anti-inflammatory effects in the RID tg lead to a significant
reduction in both IWAT and GWAT depot sizes, even in young
chow-fed mice (Figure 2C). HFD feeding causes an even more
dramatic difference with respect to the visceral GWAT and
MWAT depots, while the subcutaneous IWAT depot no longer
differs in size from the wild-type controls under these conditions
(Figure 2D). BAT weights are similar between genotypes, with or
without HFD challenge (data not shown). Despite the reduced
overall amounts of white adipose tissue, the RID tg mice do
not display altered overall body weight (Figure S2C).
Body composition, as assessed by NMR, confirmed a slightly
reduced fat mass in both the dnTNF and the RID tg mice
compared to wild-type controls, and as little as 2 days of HFD
feeding enhances this difference between genotypes (Figures
S2D and S2E). Lean body mass was however unaltered in both
mouse models (Figures S2D and S2E). We also investigated
whether these transgenic mice display an altered energy
balance, but neither food intake nor oxygen consumption
differed from their respective controls (data not shown). Thus,
the reduced body weight in the dnTNF must be caused by an
alteration in energy balance that is too small to be detected
with available methods. In contrast, the respiratory quotient
(RQ = VO2/VCO2) was significantly altered. HFD-fed dnTNF tg(C) IWAT and GWAT in relation to body weight in chow-fed male RID tg and wild
(D) IWAT, GWAT, and MWAT in relation to body weight in 15-week HFD-fed mal
(E) Representative H&E stain of IWAT and GWAT in male RID tg and wild-type m
(F) Adiponectin levels in male RID tg and wild-type mice on chow and after 12 w
(G and H) Glucose tolerance in (G) chow-fed and (H) 12-week HFD-fed male RID
(I) Serum-insulin levels in 3 hr fasted male RID tg and wild-type mice. One-way AN
p = 0.004) contribute significantly to collagen levels. Error bars represent SEM; p <
by */#; **/##p < 0.01; ***/###p < 0.001 (*difference in between genotype, #differenc
time courses according to repeated-measurement ANOVA.mice display a lower RQ in the dark phase, and the RID tg
mice display a lower dark phase-RQ on both chow and HFD.
This reduction in RQ in both dnTNF and RID tg mice compared
to their controls indicates a heavier reliance on FA oxidation for
their energy need (Figures S2F and S2G). Typically, healthy
mice burn carbohydrates during the dark phase. At this time of
day, they have the highest food intake and hence the highest in-
sulin levels. Thus, a lower RQ during the dark phase, reflective of
reduced carbohydrate use, is an indication of systemic insulin
resistance and metabolic inflexibility in both transgenic strains.
The inhibition of adipogenesis (as gauged by the estimated
number of adipocytes) is even more pronounced in the RID tg
mice (Figure 2E). Chow-fed RID tg mice display 17% ± 2% larger
adipocytes in IWAT (p < 0.05) and a trend toward larger adipo-
cytes in GWAT (27% ± 11% larger, p = 0.14) despite the fact
that these depots are 25% (IWAT) and 30% (GWAT) smaller
than in wild-type controls (Figure 2C). The circulating SAA levels
are, to our surprise, higher in chow-fed RID tg mice, but this
difference disappears on HFD; i.e., the HFD-induced increase
in SAA is more pronounced in wild-type mice (Figure S2H).
Similar to the dnTNF tg mice, the RID tg adipose phenotype is
associated with both reduced adiponectin levels and glucose
intolerance (Figures 2F and 2G). In fact, RID tg mice have a sub-
stantial degree of glucose intolerance with mild hyperinsulinemia
already under unchallenged, chow-fed conditions at a young
age. It could very well be that the lower adiponectin levels
contribute to this impaired insulin sensitivity. HFD feeding aggra-
vates the metabolic phenotype further, and the RID tg mice
continue to display reduced glucose tolerance despite severe
hyperinsulinemia relative to the wild-type controls (Figures 2H
and 2I). Upon closer analysis of the adipose tissue, we found
elevated levels of collagen in HFD-fed RID tg IWAT. Interestingly,
in these experiments, we noticed that HFD induces a rapid and
dramatic reduction of septa in IWAT. These septa are easily
detectable with a Picrosirius red stain, while somewhat less
apparent with Trichrome stain, and correspond to collagen
streaks that compartmentalize adipose tissue ‘‘units’’ in young
wild-type mice (Figures 3A and S3A). There is no description in
the literature of either the developmental origin or the relevance
of these functional ‘‘miniunits’’ in adipose tissue. The reduction in
septa can be quantified by total collagen measurements. HFD-
fed wild-type, but not RID tg, mice have a reduced total amount
of collagen per milligram adipose tissue compared to the levels
in chow-fed controls (Figure 3B). Thus, adipose tissue fibrosis
in obesity may, at least in some cases, be the consequence of
reduced ECM degradation, rather than an increase in ECM
production.We should also note that total collagen content mea-
surements of adipose tissue do not necessarily reflect states of
pathological fibrosis, since healthy chow-fed mice have higher-type mice.
e RID tg and wild-type mice.
ice on chow.
eeks of HFD.
tg and wild-type mice.
OVA analysis shows that both diet (F = 8.1, p = 0.013) and genotype (F = 12.3,
0.05 according to Student’s t test was considered significant and is indicated
e from initial weight). p values in red indicate difference between groups during
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Figure 3. Increased HFD-Induced Steatosis and Delayed Adipose Tissue Development in dnTNF and RID tg Mice
(A) Representative Picrosirius red stain of IWAT from 8-week-old C57B6 males on chow and after 9 days with HFD.
(B) Representative Trichrome stain and collagen levels in IWAT of HFD-fed male RID tg and wild-type mice.
(C) Representative H&E stain of liver sections from 11-week HFD-fed male dnTNF tg and littermate control.
(D) Liver fat quantified by CT and liver weight in 11-week HFD-fed male RID tg and wild-type controls.
(E and F) Representative H&E stain of IWAT and GWAT sections and endomucin immune stain of IWAT (bottom panels) and (with quantification shown in F) from
10-day-old male RID tg and wild-type pups.
(G) Body weight, IWAT weight, and adipocyte sizes in 10-day-old dnTNF tg and littermate controls. Error bars represent SEM; p < 0.05 according to Student’s t
test was considered significant and is indicated by */#; **p < 0.01; ***p < 0.001 (*significantly different from WT, #significantly different from untreated controls of
same genotype).
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mice. Instead, these data suggest that, beyond biochemical
measurements, a histological examination also has to be per-
formed to accurately assess whether a pathological condition
prevails (e.g., the collagen deposits show up as irregular streaks
or in association with CLSs) or whether the collagen deposits are
in the form of well-organized septa, as seen in the lean animals.
Reduced HFD-Induced Adipose Tissue Expansion in
dnTNF and RID tg Mice Is Associated with Hepatic
Steatosis
These initial observations support the hypothesis that the ability
to mount a proinflammatory response is intimately coupled to
adipose tissue expansion, proper remodeling, and the resolution
of inflammation. We therefore wanted to determine whether
the reducedstoragecapacity in adipose tissue leads to increased
ectopic lipid deposition. Indeed, both the dnTNF and the RID tg
mice display an increased degree of HFD-induced hepatic stea-
tosis (Figures 3Cand3D). Given the bluntedHFD-inducedweight
gain in the dnTNF tg mice and the higher anti-inflammatory po-
tency of the RID transgene, it is not surprising that the effects
on the liver are more severe in the RID tg mice. In addition to
the increased amounts of liver fat, RID tg mice also display a
high level of hepatomegaly during HFD-fed conditions
(Figure 3D). Thus, the increased ectopic lipid deposition in dnTNF
and RID tg mice can, at least in part, explain the more severe
degree of HFD-inducedmetabolic dysfunction compared to con-
trols in these mouse models.
Adipocyte Inflammation Is Important for Early Postnatal
Adipogenesis
The observations so far argue that the reduced adipose tissue
mass in the dnTNF and the RID tg mice is the consequence of a
decreased adipogenesis rate, partially offset by a more pro-
nounced hypertrophy of existing adipocytes. Moreover, the
reduced overall fat mass cannot solely be the consequence of
an altered energy balance, since only the dnTNF, but not the RID
transgenic, mice display lower body weights; and adipose depot
sizes in both the dnTNFand theRID tgmicearedisproportionately
reduced beyond what is expected from the body weight differen-
tials to wild-type mice. We were therefore prompted to further
explore the phenomenon of reduced adipose expansion and
remodeling in these anti-inflammatory models. First, we explored
whether adipogenesis is already negatively affected during post-
natal development. Immediately at birth, wild-type mice rapidly
expand their IWAT depots. IWAT pads grow substantially within
1–2weeks,while the visceral adiposedepots remainalmost unde-
tectable at this young age. We measured the differences in
adipose tissue size in 10-day-old pups. Indeed, the RID tg pups
display fewer, but larger, adipocytes in developing IWAT, while
body weights are unaltered compared to wild-type controls
(Figures 3E and 3F and data not shown). This difference is associ-
atedwith adecrease in vascular density as judgedby IHCstainsof
endomucin of IWAT (Figures3Eand3F). ThednTNFmicedisplaya
similar, albeit less dramatic, phenotype. The 10-day-old dnTNF tg
pups have a slightly reduced total body weight, though the IWAT
weight is reduced both in relation to body weight and in absolute
terms compared to littermate controls (Figure 3G). The dnTNF
adipocytes in GWAT are larger, while the adipocytes in IWAT areof similar size compared to wild-type adipocytes on postnatal
day 10 (Figure 3G). Even the dnTNF tg mice have therefore a
reduced number of adipocytes, since the adipose depots are
overall smaller. There is no evidence of dead adipocytes in either
GWAT or IWAT in any of the genotypes (Figure S3B for RID tg;
data not shown for dnTNF tg).
A concern in this context is that both RID tg and dnTNF could
lead to inhibition of adipogenesis due to cytotoxic effects or due
to unspecific interference with the differentiation program. To
investigate this possibility, we isolated stromal vascular cells
from IWAT of wild-type, dnTNF, and RID tg mice; propagated
them in culture; and then subjected the cells to an in vitro differ-
entiation protocol and assessed the degree of differentiation by
several different criteria (Figures S3C–S3E). All three cell prepa-
rations differentiated to the same extent as judged by appear-
ance of lipid droplets in bright field microscopy (Figure S3C),
oil red O staining (Figure S3D), and immunoblotting for the
adipocyte marker adiponectin (Figure S3E). Thus, the reduced
adipogenic potential in the transgenic mice is truly a function
of the reduced ability of these cells to respond to external
proinflammatory stimuli in the context of an intact adipose tissue
depot, rather than a cell-autonomous differentiation defect due
to transgene expression.
The first few postnatal days are associated with an increased
exposure to many new antigens due to microbial colonization
of the gut, concomitant with a sudden intake of large quantities
of milk. A large intake of lipids has been shown to acutely
cause inflammatory responses in various tissues, including
adipose tissue (Asterholm et al., 2012; Magne et al., 2010).
We hypothesize that the likely increase in the systemic levels
of bacterial toxins further elevates the lipid-induced proinflam-
matory response, and facilitates angiogenesis that in turn is
permissive for adipogenesis (Figure S4A). Hence, we suggest
that gut bacteria play a major role in proper storage of excess
nutrients during this early postnatal stage. To test this hypoth-
esis, we exposed wild-type and RID transgenic mice for
5 weeks prior to mating to a chow diet supplemented with
antibiotics that effectively deplete the commensal microflora
(Rakoff-Nahoum et al., 2004). The antibiotics were removed
from the food between E0 and E16 and were reintroduced
again at day E17 to avoid potentially harmful effects of these
drugs on fetal development. There was no effect on the
offspring’s body weight, neither by antibiotics nor by genotype,
and all pups survived and appeared healthy regardless of
treatment group. We found that antibiotic-treated wild-type
offspring display reduced amounts of adipose tissue at
10 days of age compared to the untreated control mice. The
RID tg pups display a reduced amount of adipose tissue rela-
tive to wild-type mice, regardless of whether they were on
antibiotics or not (Figure 4A). Thus, the presence or absence
of bacterially derived toxins in the RID tg pups has no effect
on adipose tissue growth, supporting the notion that a local
inflammatory response is an important component of normal
adipose tissue expansion. Furthermore, the male breeders
used in this study were sacrificed after 5 weeks of treatment,
and their MWAT was collected for histological analysis. We
found that antibiotic-treated wild-type mice have a reduced
capillary density in their MWAT compared to controls (Figure 4B).
This observation provides additional support for the ideaCell Metabolism 20, 103–118, July 1, 2014 ª2014 Elsevier Inc. 109
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Figure 4. Ablation of Gut Microbiota Affects Capillary Density, and Ad-rtTA-TRE-IkB tg Mice Display Reduced Adipogenesis and Glucose
Tolerance
(A) Effect of antibiotics treatment on IWAT weight in 10-day-old RID tg and wild-type pups. One-way ANOVA analysis shows that both treatment (F = 5.3,
p = 0.026) and genotype (F = 29.4, p < 0.001) contribute significantly to the IWAT weight.
(B) Effect of antibiotics treatment on capillary density in MWAT as judged by endomucin immune stain in male RID tg and wild-type mice. One-way ANOVA
analysis shows that both treatment (F = 35.1, p = 0.002) and genotype (F = 14.8, p = 0.012) contribute significantly to capillary density in MWAT.
(C) Body weight and IWAT weight in doxycycline-treated 10-day-old Ad-rtTA-TRE-IkB tg and littermate controls.
(D) Body weight and glucose tolerance in 8-week HFD-fed male Ad-rtTA-TRE-IkB tg and littermate controls.
(E) Dissected tissue weight in 8-week HFD-fed Ad-rtTA-TRE-IkB tg and littermate controls. Error bars represent SEM; p < 0.05 according to Student’s t test was
considered significant and is indicated by */#; **/##p < 0.01; ***p < 0.001 (*significantly different fromWT, #significantly different from untreated controls of same
genotype). p value in red indicates difference between groups during the indicated time course according to repeated-measurement ANOVA).
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genesis, at least locally in MWAT (Figure S4B). RID tg mice had
a reduced capillary density, even in the absence of antibiotic
treatment (Figure 4B). Furthermore, the average MWAT adipo-
cyte size is 20% ± 5% (p < 0.05) larger, while the MWAT depot110 Cell Metabolism 20, 103–118, July 1, 2014 ª2014 Elsevier Inc.weight is 73% ± 7% reduced, indicating a dramatic reduction
in the number of MWAT adipocytes in RID tg mice compared to
wild-type controls. Antibiotic treatment did not have an impact
on adipocyte size, but tended to reduce the capillary density
even further in the RID tg MWAT, suggesting that additional cells
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Inflammation and Adipose Tissue Expansionbeyond adipocytes play a role in the response tomicrobial toxins
in adult MWAT (Figure 4B).
Reduced Adipogenesis and HFD-Induced Glucose
Intolerance in an Inducible Adipocyte-Specific
Anti-Inflammatory Model
Since the effects seen in adipose tissue expansion and meta-
bolic health were quite striking in the RID tg and dnTNF mice,
we wanted to test whether we could see a similar phenomenon
in an adipocyte-specific inducible model. To that end, we
generated a mouse that expresses a mutated human Ik
Ba(S32G-S36A) version under the control of a tet-responsive
element (TRE-IkB tg). IkBa(S32G-S36A) is an effective inhibitor
of the NFkB pathway. This TRE-IkB tg model was crossed
with transgenic mice expressing the ‘‘tet-on’’ transcription fac-
tor rtTA under the control of the highly adipocyte-specific
adiponectin promoter (Ad-rtTA tg) (Wang et al., 2010). Upon
exposing Ad-rtTA-TRE-IkB tg mice to doxycycline, Ik
Ba(S32G-S36A) mRNA gets selectively induced in adipocytes,
whereas no expression is observed in other tissues, such as
the liver (Figure S4C). When we analyzed the impact of the
expression of this anti-inflammatory protein during late gesta-
tion and the first 10 days of the postnatal period by exposing
both wild-type and transgenic dams to doxycycline, the pups
expressing IkBa(S32G-S36A) displayed a reduced IWAT
weight, while no effect on body weight was observed (Fig-
ure 4C). The adipocyte sizes were, however, similar between
genotypes (data not shown), arguing for lower total number of
inguinal adipocytes in 10-day-old Ad-rtTA-TRE-IkB tg pups.
Similar to the other models, there was no evidence of any
dead adipocytes, as judged by perilipin stain (data not shown).
We investigated the metabolic phenotype of Ad-rtTA-TRE-
IkB tg mice. We found no difference between genotypes in
either body weight or glucose tolerance on doxycycline-supple-
mented chow (data not shown). Challenging the mice with HFD
for 8 weeks, however, revealed a significant difference between
genotypes. Ad-rtTA-TRE-IkB tg mice were more glucose intol-
erant than littermate controls, despite comparable body
weights (Figure 4D). Similar to the dnTNF and the RID tg
mice, the GWAT weight was reduced, while the liver weights
were increased in the HFD-fed Ad-rtTA-TRE-IkB tg mice
(Figure 4E). In contrast, there was no difference in IWAT,
MWAT, and BAT weights (Figure 4E; data not shown). To
assess whether the Ad-rtTA-TRE-IkB tg mice are more suscep-
tible to develop HFD-induced hepatic steatosis, livers were
harvested from a second cohort of mice after 1, 6, and
10 weeks on doxycycline-supplemented HFD. We found a
strong trend toward increased HFD-induced hepatic steatosis
in relation to body weight (Figure S4D). These findings confirm,
in a third independent system, that the inability to mount a
proinflammatory response in adipose tissue impairs adipose
tissue expansion associated with metabolic dysfunction.
Impaired b3-Adrenergic Receptor Agonist-Induced
Adipose Tissue Remodeling in RID tg Mice
The adipose tissue response to chronic b3-adrenergic receptor
(AR) agonist involves a transient acute bout of inflammation
and, over time, triggers ‘‘browning’’ of the IWAT as defined by
an increased number of multilocular cells expressing uncouplingprotein (UCP)-1 (Granneman et al., 2005; Mottillo et al., 2010).
There is also evidence for increased adipogenesis in GWAT in
response to chronic b3-AR-agonist treatment (Lee et al., 2012;
Wang et al., 2013). We aimed to investigate whether adipose
tissue ‘‘beiging’’ depends on a proinflammatory response. We
examined one of our models, the RID tg mice and exposed
them and their wild-type controls to daily b3-AR-agonist and bro-
modeoxyuridine (BrdU) injections for 10 days. Rather dramatic
differences were apparent with respect to the response to this
chronic b3-AR-agonist treatment. Wild-type adipose tissues
displayed amuch ‘‘browner’’ color than the RID tg adipose tissue
(Figure 5A), and IWAT contained a large number of multilocular
adipocytes, while RID IWAT only displays a modest response
in this respect (Figure 5B). In line with these observations, the
resulting UCP-1 mRNA levels are also reduced in both IWAT
and GWAT in the RID tg mice (Figure S5A). Furthermore, very
few BrdU-positive adipocytes were found in GWAT after chronic
b3-AR-agonist in RID tg mice, while several positive cells are
found in the wild-type GWAT (Figure 5C). We measured b3-AR
mRNA expression as well as the acute lipolytic response to
b3-AR-agonist treatment and found no difference in b3-AR
expression (Figure S5A). The b3-AR-agonist-induced serum
FFA increase is just marginally affected in the RID mice (Fig-
ure S5B). This eliminates receptor abundance and activity as a
trivial explanation for these findings. Along the same rationale,
receptor abundance and signaling are therefore unlikely to
explain the differences in b3-AR agonist-induced ‘‘beiging’’ be-
tween genotypes. We have previously reported that inducible
adipocyte-specific expression of VEGF-A leads to a ‘‘browning’’
of adipose tissue, similar to the effects reported for chronic b3-
AR agonist treatment (Sun et al., 2012). Therefore, we specu-
lated that the lack of b3-AR agonist induced-‘‘beiging’’ in the
RID tg mice may relate to a reduced ability to induce proangio-
genic mediators. Indeed, upon examining the gene expression
response in IWAT within 3 hr of a single dose of b3-AR agonist,
we find a blunted induction of several proinflammatory cytokines
in the RID tg mice (Figure 5D). Furthermore, the mRNA expres-
sion levels of classical proangiogenic mediators, such as
VEGF-A, angiopoetin-1, and angiopoetin-2 (Angpt1 and Angpt2)
are also reduced in the b3-AR agonist-treated RID tg mice (Fig-
ure 5D). Notably, we did not detect an acute b3-AR agonist-
mediated induction of these proangiogenic mediators in the
wild-type mice. Rather, the difference between genotypes re-
lates mainly to a downregulation of these particular genes in
response to b3-AR agonist in the RID tg mice. Thus, in the
context of acute b3-AR agonist stimulation, it seems that a potent
inflammatory response is necessary to maintain the expression
of VEGF-A, Angpt1, and Angpt2 in IWAT. A comparable gene
expression pattern was also seen in GWAT, albeit the individual
variation is larger than in IWAT (Figure S5C).
The Reduced MWAT Expansion in the RID tg Mice Is
Associated with a ‘‘Leaky Gut’’
The RID tg mice have a more severe metabolic phenotype than
the dnTNF tg and the Ad-rtTA-TRE-IkB tg mice. It caught our
attention that the dnTNF tg and the Ad-rtTA-TRE-IkB tg mice
display a normal HFD-inducedMWAT expansion andmesenteric
adipocyte size (data not shown). In contrast, MWAT expansion is
dramatically reduced in theRID tgmice (Figure 2D). This indicatesCell Metabolism 20, 103–118, July 1, 2014 ª2014 Elsevier Inc. 111
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Figure 5. Reduced b3AR-Agonist-Induced Browning of White Adipose Tissue in RID tg Mice
(A) Photo of IWAT andGWAT harvested frommale RID tg andwild-typemice after chronic b3-AR-agonist treatment (10 days with daily i.p injection with 1mg/kg in
PBS).
(B) Representative H&E stain of IWAT from male RID tg and wild-type mice after chronic b3-AR-agonist treatment.
(C) Representative BrdU immunostain of GWAT harvested after chronic b3-AR-agonist treatment (coadministered with 10 mg/kg BrdU) in male RID tg and wild-
type mice. Orange arrows point toward BrdU-positive nuclei.
(legend continued on next page)
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compensated for by an increase in other inflammatory signaling
pathways in the mesenteric area. These compensatory mecha-
nisms are, however, not present or effective in GWAT or IWAT.
Moreover, the glucose intolerance seen in young unchallenged
RID tg mice cannot be explained by hepatic steatosis, since
comparably low levels of hepatic lipids are seen between
chow-fed wild-type and RID tg mice, at least while the body
weights are<30g (Figure 6A).Wenoted, however, that SAA levels
are increased and both the liver size and the average size of the
individual hepatocytes are enlarged in the chow-fed RID tg
mice, even in the absence of steatosis (Figures S2H, 6B, and
6C). Furthermore, the spleensof theRID tgmiceare alsoenlarged
(Figure 6D). Taken together, these observations argue for a state
of elevated hepatic stress and increased systemic immune acti-
vation in the RID tg mice. A likely explanation for these phenom-
ena is an increased exposure to bacterial toxins that are leaking
out from the gut. In line with this hypothesis, we found elevated
levels of anti-LPS IgGs and increased intestinal permeability as
judged by the circulating levels of FITC-dextran after an oral
load in young RID tg mice (6–8 weeks old with a body weight of
%20 g) on a chow diet (Figures 6E and 6F). Treatment with 2%
dextran sulfate sodium (DSS) through drinking water, which
damages the colonic epithelium, increases permeability and
causes colitis, leads to a further elevation of anti-LPS IgGs levels
and serves as a positive control for the plasma anti-LPS IgG
assay (Figure 6E). The colons of the DSS-treated RID tg mice
display increased pathological changes, such as an increased
degree of colon hyperplasia, more severe crypt disruption and
leukocyte infiltration, and further increasedspleen size compared
to the DSS-treated wild-type mice (Figures 6G and 6H). Further-
more, the DSS-treated RID tgmice have increased expression of
CD14, TLR4, TNF-a, MCP-1, MIP-1a, F4/80, and MPO mRNA in
colon, which supports the histological findings and indicates that
there is a higher degree of inflammation, with enhanced recruit-
ment/infiltration of macrophages and neutrophils, compared to
the DSS-treated wild-type mice (Figure 7A). It should also be
noted that even the non-DSS-treated RID tg mice display mild
colon hyperplasia and elevated colon expression of CD14 and
SAA3 mRNA (Figures 6G and 7A).
Despite the lack of an effect on body weight, DSS treatment
does, however, impair glucose tolerance in regular wild-type
mice (Figure S6A). This suggests that impaired intestinal barrier
function alone (even in the absence of HFD) can have a negative
impact on systemicmetabolic regulation. This also suggests that
at least some of the RID tg phenotype may be improved if expo-
sure to bacterial toxins is limited. We put this hypothesis to the
test and found that indeed, a 5-week antibiotics treatment nor-
malizes spleen size and insulin levels in the transgenic mice (Fig-
ures 7B and 7C). To a large extent, the expression of the liver
acute phase reactants SAA1 and SAA2 is also lowered to levels
seen in the untreated wild-type mice (Figure 7D). These data
suggest that RID tg mice suffer from impaired intestinal barrier
function, leading to ‘‘leaky gut’’ and colitis. This also provides(D) Gene expression analyses of IWAT 3 hr (acute) after b3-AR-agonist injection an
tg and wild-type mice. Error bars represent SEM; p < 0.05 according to Stude
(*significantly different fromWT, #significantly different from untreated controls of s
Figure 4D (Table S3).an explanation for their hepatomegaly, spleen enlargement,
and glucose intolerance, even in the absence of an exogenous
inflammatory challenge.
In contrast to the RID tg mice, the dnTNF tg and the Ad-rtTA-
TRE-IkB tgmice, with their associated normalMWAT expansion,
do not display hepatomegaly, enlarged spleen, or colon hyper-
plasia (data not shown). This leads us to conclude that MWAT
inflammation and its subsequent expansion is an adaptive
response that plays a significant role in sustaining proper intes-
tinal barrier function and healthy symbiosis between the
commensal microflora and the host.
The intestinal barrier is, however, not only preventing bacte-
rial toxins from leaking out, but it also contributes to a healthy
symbiosis with colonizing bacteria. An impaired intestinal bar-
rier and/or chronic inflammation may lead to unfavorable shifts
in microbial composition. This is based on the observation that
gut flora can be transferred from mouse to mouse and affect
the pathogenesis of obesity and hepatic steatosis (Garrett
et al., 2010; Henao-Mejia et al., 2012). As expected, we found
a difference in bacterial composition as judged by qPCR anal-
ysis of eight different bacterial strains of DNA isolated from
cecal content from wild-type and RID tg mice housed in
different cages. Cecal levels of Lactobacillus murinus, Mucis-
pirillum Schaedleri, and Eubacterium Plexicaudatum were
increased, and there was a trend for reduced levels of
Firmicutes sp. In contrast, the levels of Lactobacillus sp.,
Clostridium sp., and B. Distasonis-Porphyromonas were similar
between RID tg and wild-type mice (Figure S6B). Differences in
bacterial composition are not necessarily a reflection of a direct
negative effect of the RID tg transgene on intestinal barrier
function but can also be secondary to metabolic disturbances
and also differ between litters and cages. Importantly, the
metabolic dysfunction in RID tg is apparent regardless of
whether the mice under comparison are littermates or not.
Furthermore, there is no difference in either HFD-induced
body weight gain, glucose tolerance, insulin levels, or hepatic
steatosis in wild-type mice cohoused either with unrelated
wild-type mice or with RID tg (data not shown). Thus, the
potential negative effect of an altered bacterial composition in
the RID tg mice is not potent enough to have an impact on
metabolic health in the context of a normal immune defense
in wild-type mice. We can also conclude that the wild-type
gut flora does not offer a significant protective effect on the
metabolic phenotype in the RID tg mice.
DISCUSSION
The data presented here argue that a reduced ability to sense
and respond to proinflammatory stimuli at the level of the
adipocyte decreases the capacity for healthy adipose tissue
expansion and remodeling. This inability results in increased
HFD-induced hepatic steatosis and metabolic dysfunction.
Interestingly, while the ability to sense proinflammatory cues
that trigger expansion is of importance for all fat pads, ad after chronic treatment (IWAT harvested 24 hr after last injection) in male RID
nt’s t test was considered significant and is indicated by */#; **/##p < 0.01
ame genotype). Additional one-way ANOVA analyses have been performed for
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Figure 6. Leaky Gut and Colitis Associated with Signs of Systemic Inflammation in RID tg Mice
(A) Liver fat quantified by CT in chow-fed male RID tg and wild-type mice.
(B and C) (B) Liver weight and (C) representative H&E stain of liver sections to show hepatocyte size in chow-fed male RID tg and wild-type mice with a body
weight < 30 g.
(D) Spleen size in chow-fed RIDs chow-fed male RID tg and wild-type mice.
(E) Serum levels of anti-LPS IgG in young chow-fed versus DSS-treated male RID tg and wild-type mice. One-way ANOVA analysis shows that both treatment
(F = 78.8, p < 0.001) and genotype (F = 26.4, p < 0.001) contribute significantly to anti-LPS IgG levels.
(F) Serum levels of FITC-dextran after an oral load in young chow-fed female RID tg and wild-type mice.
(G andH) (G) Colonweight/length ratios, representative H&E images of colon, and (H) spleen weight in untreated, and in response to DSS-treated, male RID tg and
wild-type mice. One-way ANOVA analysis shows that both treatment (F = 153.6/ 47.3, p < 0.001/ < 0.001) and genotype (F = 27.4/13.9, p < 0.001/0.05) contribute
significantly to both colon thickness and spleen size. Error bars represent SEM; p < 0.05 according to Student’s t test was considered significant and is indicated
by */#; **/##p < 0.01; ***/###p < 0.001 (*significantly different fromWT, #significantly different from untreated controls of same genotype). p value in red indicates
differences between groups during time course according to repeated-measurement ANOVA.
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Figure 7. Antibiotics Treatment Improves the RID tg Mouse Phenotype
(A) Gene expression analysis of proximal colon in untreated, and in response to three bouts of DSS treatments, in male RID tg and wild-type mice.
(B–D) (B) Spleen, (C) fasting serum-insulin, and (D) SAA1 and SAA2 mRNA levels in liver in control or antibiotic-treated male RID tg and wild-type mice. One-way
ANOVA analysis shows that both treatment (F = 15.8/8.7/12.1/5.8, p = 0.001/0.003/0.004/0.03) and genotype (F = 19.3/17.1/23.6/31.8, p < 0.001/0.001/ < 0.001/
< 0.001) contribute significantly to spleen size, insulin levels, liver SAA1, and liver SAA2 levels.
(E) Summary and proposed model: Acute inflammation is essential for healthy adipose tissue expansion and proper remodeling. Inability of adipose tissue to
accurately sense and respond to inflammatory stimuli leads to reduced adipose tissue expansion and an increased risk for microbial translocation. Error bars
represent SEM; p < 0.05 according to Student’s t test was considered significant and is indicated by */#; **/##p < 0.01; ***p < 0.001 (*significantly different from
WT, #significantly different from untreated controls of same genotype).
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for the functionality of the visceral MWAT depot. We observe that
the lack of MWAT expansion is associated with increased intes-
tinal permeability and colitis, resulting in chronic systemic inflam-
mation and metabolic dysfunction, even in the absence of HFD.
The Underlying Mechanism for Inflammation-Induced
Adipose Tissue Expansion
Adipose tissue expands either through hypertrophy of existing
adipocytes or adipogenesis, i.e., differentiation of new adipo-
cytes from adipogenic precursor cells. All models studied here
establish a reduced number of adipocytes in most depots
examined. Chronic HFD feeding leads to a more pronounced
GWAT depot weight difference, while the IWAT depot weight
differences between tg and wild-type mice are reduced. Never-
theless, both GWAT and IWAT depots are at all times populated
by fewer adipocytes in the transgenic mice than in the wild-type
mice, reflecting a reduced rate of adipogenesis. Thus, the ability
to mount an acute inflammatory response is playing a more
important role in facilitating adipogenesis than in adipocyte
hypertrophy.
The concept of inflammation-driven adipogenesis may seem
contradictory at first, since proinflammatory cytokines, such as
TNF-a, are lipolytic and block adipocyte differentiation in vitro
(Gustafson and Smith, 2006). The situation in vitro is, however,
substantially different from the situation in vivo, since there is
neither a need for angiogenesis nor ECM remodeling under
in vitro conditions. In fact, several older studies support a role
of local inflammation in increased adipogenesis. For instance,
Sadler and colleagues show that low-dose LPS leads to adipo-
cyte hyperplasia at the site of administration (Sadler et al.,
2005), and there is a selective increase in the amount of MWAT
in Crohn’s disease as well as in experimentally induced colitis
(Gambero et al., 2007; Sheehan et al., 1992). Moreover, a very
recent study on proliferation and differentiation of PDGFRa+
adipocyte progenitors in vivo demonstrates that different adipo-
genic conditions are associated with an upregulation of different
sets of inflammatory andmacrophage-associated genes in white
adipose tissue (Lee et al., 2013).
It is likely that several distinct mechanisms contribute toward
the inflammation-driven adipogenic response, with several inter-
connected processes triggering adipose tissue growth. Here, we
found that HFD feeding acutely (within days) leads to a reduction
of the total levels of collagen in IWAT in wild-typemice, but not to
the same extent in the dnTNF and the RID tg mice. Thus, healthy
adipose tissue expansion is associated with a net loss of adipose
tissue collagen, while dysfunctional adipose tissue in more
advanced obesity displays an increased number of ECM
deposits, along with chronic inflammation and hypoxia. The
inability to effectively degrade ECM limits the capacity for
healthy adipose tissue expansion. RID tg adipose tissue also
has a reduced capillary density. In line with this finding, the capil-
lary density of wild-type MWAT gets reduced by ablation of gut
microbiota. These data demonstrate that proinflammatory
responses in adipose tissue are essential for both proper ECM
remodeling and angiogenesis, two processes known to facilitate
adipogenesis in vivo, and therefore are likely mediators of the
inflammation-induced adipose tissue expansion phenomenon
(Cao, 2007; Cristancho and Lazar, 2011).116 Cell Metabolism 20, 103–118, July 1, 2014 ª2014 Elsevier Inc.Chronic systemic inflammation interferes with optimal
metabolic fitness. However, in light of our findings in three
independent adipocyte anti-inflammatory models (summarized
in Table S1), the view of adipose inflammation as a driving force
for systemic inflammation and metabolic dysfunction is an
oversimplification. Rather, we postulate that a potent acute
inflammatory response is essential for adipose tissue protection,
remodeling, and expansion (Figure 7E). This facilitates the return
to a healthy equilibrium with metabolic homeostasis that subse-
quently allows the inflammation to reach resolution as opposed
to becoming chronic.
EXPERIMENTAL PROCEDURES
Animals
Adipochaser mice were described in Wang et al. (2013). aP2-dnTNF, aP2-
RID, and TRE-IkBa(S32G-S36A) transgenic mice were used in a pure
C57B6/J (dnTNF and TRE-IkB) or on a FVB background (RID). Mice were
maintained on a 12 hr dark/light cycle and housed in groups of four to five
with unlimited access to water, chow (number 5058, Lab-Diet) or HFD
(number D12492, Research Diets Inc.) as indicated for the individual experi-
ments. In all experiments, littermate controls were used unless specifically
stated otherwise. The Institutional Animal Care and Use Committee of the
University of Texas Southwestern Medical Center, Dallas, has approved all
animal experiments.
LPS-Induced Adipogenesis
Adipochaser mice were fed doxycycline-supplemented chow (600 mg/kg) for
1 week and were thereafter switched to regular chow 3 days prior the exper-
iment. The right IWAT depot of adipochaser mice was injected twice a week
for 2 weeks with 20 mg lipopolysaccharide (LPS, Sigma, USA) in 50 ml PBS,
while the left IWAT depot remained untreated. Five weeks later, tissues were
harvested for X-Gal-LacZ staining (performed as previously described
[Wang et al., 2013]).
LPS and TNFa Response In Vivo
The mice received one intraperitoneal injection with 0.3 mg/kg LPS in PBS or
0.5 mg/mouse TNFa (recombinant mouse TNFa, Biolegend, USA) in PBS
supplemented with 1% BSA. Blood was collected from the tail at indicated
time points.
Oral Glucose Tolerance Test
The mice were fasted for 3 hr during the light phase, and blood samples were
drawn from the tail vein before and 15, 30, 60, and 120min after an intragastric
load with 2.5 g/kg glucose in PBS.
Adipose Tissue Collagen Levels Measurements
Pieces of IWAT (50 mg) were snap frozen in N2 (l) until analysis. The total
collagen content was measured, using a commercial kit (QuickZyme Biosci-
ences, Netherlands).
Hepatic Steatosis Measurements
Quantification of hepatic steatosis was performed by computerized tomogra-
phy (CT) or standard biochemical tissue triglyceride analysis. The CT analysis
was performed as previously described (Asterholm and Scherer, 2010). In
brief, mice were anesthetized with Isoflurane, and a CT scan was performed
at a resolution of 93 mm using the short scan mode (180) on an eXplore Locus
in vivoMicroCT Scanner fromGEHealthcare. Liver lipid content was estimated
by obtaining the average CT value in multiple regions well within the liver, as
validated in Asterholm and Scherer (2010).
Intestinal Permeability Assay In Vivo
The mice were fasted for 5 hr; thereafter they were given an oral load with
0.6 mg/g FITC-labeled dextran (average mole weight 4000, Sigma). Blood
samples were collected at indicated time points and the serum was
diluted two times in PBS and loaded together with known standards diluted
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535 nmem) on a POLARstar Optima Analyzer.
Statistical Analysis
Data are in generally expressed as mean ± SEM. The Student’s t test and
one- or two-way ANOVA (repeated measurement) were used for compari-
sons between groups; log transformation was performed as necessary to
obtain normal distribution. SPSS software (version 21) was used for these
statistical calculations; *p < 0.05 was considered significant; **p < 0.01;
***p < 0.001.
SUPPLEMENTAL INFORMATION
Supplemental information includes Supplemental Experimental Procedures,
six figures, and three tables and can be found with this article online at
http://dx.doi.org/10.1016/j.cmet.2014.05.005.
AUTHOR CONTRIBUTIONS
I.W.A. designed the study, carried out the research, interpreted the results,
and wrote the manuscript. C.T., T.S.M., Q.A.W., F.D.-L., and Z.V.W. assisted
in study design, performed research, and reviewed the manuscript. P.E.S.
designed the study, analyzed the data, reviewed and revised the manuscript,
and is responsible for the integrity of this work. All authors approved the final
version of the manuscript.
ACKNOWLEDGMENTS
We would like to thank Dr. David E. Szymkowski from Xencor Inc. for
providing the cDNA constructs encoding dnTNFa and for his guidance on
the experimental design. We thank Dr. Bob Hammer and the Transgenic
Core Facility at UTSW for the generation of the transgenic lines, Dr. Lora
Hooper for advice on the antibiotics experiments, John Shelton and the His-
tology Core for assistance with histology, and the UTSW Metabolic Core
Unit for help in phenotyping. Supported by the National Institutes of Health
(grants R01-DK55758, R01- DK099110, and P01DK088761 to P.E.S.). I.W.A.
is supported by the Throne-Holst Foundation, the Swedish Research Council
(2006-3931 and 2012-1601), VINNOVA (2011-01336), and NovoNordisk
Excellence Project Award. Z.V.W. is supported by a postdoctoral fellowship
from the American Heart Association (10POST4320009), Q.A.W. is sup-
ported by a postdoctoral fellowship from the American Diabetes Association
(7-11-MN-47), and T.S.M. is supported by NIH Training Grant T32-
GM083831.
Received: February 11, 2014
Revised: April 9, 2014
Accepted: April 28, 2014
Published: June 12, 2014
REFERENCES
Asterholm, I.W., and Scherer, P.E. (2010). Enhanced metabolic
flexibility associated with elevated adiponectin levels. Am. J. Pathol. 176,
1364–1376.
Asterholm, I.W., McDonald, J., Blanchard, P.G., Sinha, M., Xiao, Q., Mistry, J.,
Rutkowski, J.M., Deshaies, Y., Brekken, R.A., and Scherer, P.E. (2012). Lack of
‘‘immunological fitness’’ during fasting in metabolically challenged animals.
J. Lipid Res. 53, 1254–1267.
Cao, Y. (2007). Angiogenesis modulates adipogenesis and obesity. J. Clin.
Invest. 117, 2362–2368.
Cristancho, A.G., and Lazar, M.A. (2011). Forming functional fat: a growing
understanding of adipocyte differentiation. Nat. Rev. Mol. Cell Biol. 12,
722–734.
Delgado-Lopez, F., and Horwitz, M.S. (2006). Adenovirus RIDalphabeta com-
plex inhibits lipopolysaccharide signaling without altering TLR4 cell surface
expression. J Virol 80, 6378–6386.Engelman, J.A., Berg, A.H., Lewis, R.Y., Lisanti, M.P., and Scherer, P.E. (2000).
Tumor necrosis factor alpha-mediated insulin resistance, but not dedifferenti-
ation, is abrogated by MEK1/2 inhibitors in 3T3-L1 adipocytes. Mol.
Endocrinol. 14, 1557–1569.
Gambero, A., Marostica, M., Abdalla Saad, M.J., and Pedrazzoli, J., Jr. (2007).
Mesenteric adipose tissue alterations resulting from experimental reactivated
colitis. Inflamm. Bowel Dis. 13, 1357–1364.
Garrett, W.S., Gordon, J.I., and Glimcher, L.H. (2010). Homeostasis and
inflammation in the intestine. Cell 140, 859–870.
Granneman, J.G., Li, P., Zhu, Z., and Lu, Y. (2005). Metabolic and cellular plas-
ticity in white adipose tissue I: effects of beta3-adrenergic receptor activation.
Am. J. Physiol. Endocrinol. Metab. 289, E608–E616.
Gustafson, B., and Smith, U. (2006). Cytokines promote Wnt signaling and
inflammation and impair the normal differentiation and lipid accumulation in
3T3-L1 preadipocytes. J. Biol. Chem. 281, 9507–9516.
Halberg, N., Khan, T., Trujillo, M.E., Wernstedt-Asterholm, I., Attie, A.D.,
Sherwani, S., Wang, Z.V., Landskroner-Eiger, S., Dineen, S., Magalang,
U.J., et al. (2009). Hypoxia-inducible factor 1alpha induces fibrosis and insulin
resistance in white adipose tissue. Mol. Cell. Biol. 29, 4467–4483.
Henao-Mejia, J., Elinav, E., Jin, C., Hao, L., Mehal, W.Z., Strowig, T., Thaiss,
C.A., Kau, A.L., Eisenbarth, S.C., Jurczak, M.J., et al. (2012). Inflammasome-
mediated dysbiosis regulates progression of NAFLD and obesity. Nature 482,
179–185.
Heo, S.C., Jeon, E.S., Lee, I.H., Kim, H.S., Kim, M.B., and Kim, J.H. (2011).
Tumor necrosis factor-alpha-activated human adipose tissue-derived mesen-
chymal stem cells accelerate cutaneous wound healing through paracrine
mechanisms. J. Invest. Dermatol. 131, 1559–1567.
Hotamisligil, G.S., Shargill, N.S., and Spiegelman, B.M. (1993). Adipose
expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin
resistance. Science 259, 87–91.
Khan, T., Muise, E.S., Iyengar, P., Wang, Z.V., Chandalia, M., Abate, N.,
Zhang, B.B., Bonaldo, P., Chua, S., and Scherer, P.E. (2009). Metabolic dys-
regulation and adipose tissue fibrosis: role of collagen VI. Mol. Cell. Biol. 29,
1575–1591.
Lee, Y.H., Petkova, A.P., Mottillo, E.P., and Granneman, J.G. (2012). In vivo
identification of bipotential adipocyte progenitors recruited by beta3-adreno-
ceptor activation and high-fat feeding. Cell Metab. 15, 480–491.
Lee, Y.H., Petkova, A.P., and Granneman, J.G. (2013). Identification of an
adipogenic niche for adipose tissue remodeling and restoration. Cell Metab.
18, 355–367.
Lichtenstein, D.L., Toth, K., Doronin, K., Tollefson, A.E., andWold,W.S. (2004).
Functions and mechanisms of action of the adenovirus E3 proteins. Int. Rev.
Immunol. 23, 75–111.
Magne, J., Mariotti, F., Fischer, R., Mathe, V., Tome, D., and Huneau, J.F.
(2010). Early postprandial low-grade inflammation after high-fat meal in healthy
rats: possible involvement of visceral adipose tissue. J. Nutr. Biochem. 21,
550–555.
Mottillo, E.P., Shen, X.J., and Granneman, J.G. (2010). beta3-adrenergic
receptor induction of adipocyte inflammation requires lipolytic activation of
stress kinases p38 and JNK. Biochim. Biophys. Acta 1801, 1048–1055.
Park, J., Euhus, D.M., and Scherer, P.E. (2011). Paracrine and endocrine
effects of adipose tissue on cancer development and progression. Endocr.
Rev. 32, 550–570.
Rakoff-Nahoum, S., Paglino, J., Eslami-Varzaneh, F., Edberg, S., and
Medzhitov, R. (2004). Recognition of commensal microflora by toll-like recep-
tors is required for intestinal homeostasis. Cell 118, 229–241.
Sadler, D., Mattacks, C.A., and Pond, C.M. (2005). Changes in adipocytes and
dendritic cells in lymph node containing adipose depots during and after many
weeks of mild inflammation. J. Anat. 207, 769–781.
Saika, S., Ikeda, K., Yamanaka, O., Flanders, K.C., Okada, Y., Miyamoto, T.,
Kitano, A., Ooshima, A., Nakajima, Y., Ohnishi, Y., et al. (2006). Loss of tumor
necrosis factor alpha potentiates transforming growth factor beta-mediated
pathogenic tissue response during wound healing. Am. J. Pathol. 168, 1848–
1860.Cell Metabolism 20, 103–118, July 1, 2014 ª2014 Elsevier Inc. 117
Cell Metabolism
Inflammation and Adipose Tissue ExpansionSheehan, A.L., Warren, B.F., Gear, M.W., and Shepherd, N.A. (1992).
Fat-wrapping in Crohn’s disease: pathological basis and relevance to surgical
practice. Br. J. Surg. 79, 955–958.
Steed, P.M., Tansey, M.G., Zalevsky, J., Zhukovsky, E.A., Desjarlais, J.R.,
Szymkowski, D.E., Abbott, C., Carmichael, D., Chan, C., Cherry, L., et al.
(2003). Inactivation of TNF signaling by rationally designed dominant-negative
TNF variants. Science 301, 1895–1898.
Sun, K., Wernstedt Asterholm, I., Kusminski, C.M., Bueno, A.C., Wang, Z.V.,
Pollard, J.W., Brekken, R.A., and Scherer, P.E. (2012). Dichotomous effects118 Cell Metabolism 20, 103–118, July 1, 2014 ª2014 Elsevier Inc.of VEGF-A on adipose tissue dysfunction. Proc. Natl. Acad. Sci. USA 109,
5874–5879.
Wang, Z.V., Deng, Y., Wang, Q.A., Sun, K., and Scherer, P.E. (2010).
Identification and characterization of a promoter cassette conferring adipo-
cyte-specific gene expression. Endocrinology 151, 2933–2939.
Wang, Q.A., Tao, C., Gupta, R.K., and Scherer, P.E. (2013). Tracking adipo-
genesis during white adipose tissue development, expansion and regenera-
tion. Nat. Med. 19, 1338–1344.
